Market Overview:
The global hemoperfusion cartridge market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of various diseases and disorders that require hemoperfusion for their treatment. Additionally, the growing awareness about the benefits of hemoperfusion is also propelling the demand for these cartridges globally. Based on type, charcoal hemoperfusion accounted for a major share of the global market in 2017. This segment is expected to maintain its dominance during the forecast period as well, owing to its high efficiency in removing toxins from blood. By application, overdose was observed as one of the leading segments in 2017 and this trend is anticipated to continue over the next few years as well due to rising incidences of drug abuse all over world.
Product Definition:
A Hemoperfusion cartridge is a device that is inserted into the vascular system in order to remove toxins from the blood. The importance of Hemoperfusion cartridges is that they can help to cleanse the blood of toxins, which can improve overall health.
Charcoal Hemoperfusion:
The charcoal hemoperfusion (CHP) is a procedure in which the blood is drawn from the patient and then replaced with an artificial blood substitute. The process takes place inside a special machine known as hemodialysis machine. CHP uses charcoal filters to remove contaminants from the blood, thereby increasing its efficacy and effectiveness. It also helps in increasing the life of kidneys by improving their efficiency, performance, and ability to produce hormones.
Certain Resins Hemoperfusion:
Certain resins hemerfusion is a process in which blood is drawn from the patient and then certain chemicals are introduced to stop the bleeding. Certain resins, when introduced into the blood vessels, cause them to shrink or constrict. This reduces bleeding by creating a physical barrier between the damaged tissues and organs and helps healing process along with prevention of coagulation of formed clots.
Application Insights:
The others segment held the largest market share in 2017. This is attributed to the increasing number of patients suffering from conditions such as Parkinson¢â‚¬â„¢s disease, multiple sclerosis and rheumatoid arthritis. These diseases are characterized by inflammation of the brain and/or spinal cord, which results in severe pain and disability. According to estimates published by WHO, approximately 60 million people across the world suffer from these disorders.
According to a study conducted by researchers at UHN Clinical Research Institute, patients with Parkinson¢â‚¬â„¢s disease or other movement-related neurological disorders have a higher risk of dying due to liver failure caused by hepatic encephalopathy after undergoing surgery for deep brain stimulation therapy or neurosurgery than those without these conditions.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about disorders, availability of advanced products and favorable reimbursement policies & regulatory reforms in countries, such as U.S., Canada, and Mexico.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising incidence of overdose cases due to various drugs including alcohol and opioid derivatives like heroin, morphine etc.
Growth Factors:
- Increasing incidence of chronic kidney diseases (CKD) and other renal disorders
- Growing demand for minimally invasive procedures
- Technological advancements in hemoperfusion cartridges
- Rising number of hemodialysis centers across the globe
- Increasing awareness about the benefits of hemoperfusion
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemoperfusion Cartridge Market Research Report
By Type
Charcoal Hemoperfusion, Certain Resins Hemoperfusion
By Application
Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, Others
By Companies
Baihe Medical, Baxter International, Asahi Kasei Corporation, Jafron Biomedical, Kaneka Pharma, Kangbei Medical Device, Toray Medical, Biosun Corporation, CytoSorbents
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Hemoperfusion Cartridge Market Report Segments:
The global Hemoperfusion Cartridge market is segmented on the basis of:
Types
Charcoal Hemoperfusion, Certain Resins Hemoperfusion
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baihe Medical
- Baxter International
- Asahi Kasei Corporation
- Jafron Biomedical
- Kaneka Pharma
- Kangbei Medical Device
- Toray Medical
- Biosun Corporation
- CytoSorbents
Highlights of The Hemoperfusion Cartridge Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Charcoal Hemoperfusion
- Certain Resins Hemoperfusion
- By Application:
- Overdose
- Specific Intoxications
- Certain Autoimmune Diseases
- Hepatic Encephalopathy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemoperfusion Cartridge Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A hemoperfusion cartridge is a device that helps to increase the flow of blood through the body. Hemoperfusion cartridges are inserted into the veins in your arm and used to help increase the amount of blood that flows through your veins. This can help to improve your circulation and reduce inflammation in your tissues.
Some of the key players operating in the hemoperfusion cartridge market are Baihe Medical, Baxter International, Asahi Kasei Corporation, Jafron Biomedical, Kaneka Pharma, Kangbei Medical Device, Toray Medical, Biosun Corporation, CytoSorbents.
The hemoperfusion cartridge market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hemoperfusion Cartridge Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hemoperfusion Cartridge Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hemoperfusion Cartridge Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hemoperfusion Cartridge Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hemoperfusion Cartridge Market Size & Forecast, 2018-2028
4.5.1 Hemoperfusion Cartridge Market Size and Y-o-Y Growth
4.5.2 Hemoperfusion Cartridge Market Absolute $ Opportunity
Chapter 5 Global Hemoperfusion Cartridge Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hemoperfusion Cartridge Market Size Forecast by Type
5.2.1 Charcoal Hemoperfusion
5.2.2 Certain Resins Hemoperfusion
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hemoperfusion Cartridge Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hemoperfusion Cartridge Market Size Forecast by Applications
6.2.1 Overdose
6.2.2 Specific Intoxications
6.2.3 Certain Autoimmune Diseases
6.2.4 Hepatic Encephalopathy
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hemoperfusion Cartridge Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hemoperfusion Cartridge Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hemoperfusion Cartridge Analysis and Forecast
9.1 Introduction
9.2 North America Hemoperfusion Cartridge Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hemoperfusion Cartridge Market Size Forecast by Type
9.6.1 Charcoal Hemoperfusion
9.6.2 Certain Resins Hemoperfusion
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hemoperfusion Cartridge Market Size Forecast by Applications
9.10.1 Overdose
9.10.2 Specific Intoxications
9.10.3 Certain Autoimmune Diseases
9.10.4 Hepatic Encephalopathy
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hemoperfusion Cartridge Analysis and Forecast
10.1 Introduction
10.2 Europe Hemoperfusion Cartridge Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hemoperfusion Cartridge Market Size Forecast by Type
10.6.1 Charcoal Hemoperfusion
10.6.2 Certain Resins Hemoperfusion
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hemoperfusion Cartridge Market Size Forecast by Applications
10.10.1 Overdose
10.10.2 Specific Intoxications
10.10.3 Certain Autoimmune Diseases
10.10.4 Hepatic Encephalopathy
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hemoperfusion Cartridge Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hemoperfusion Cartridge Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hemoperfusion Cartridge Market Size Forecast by Type
11.6.1 Charcoal Hemoperfusion
11.6.2 Certain Resins Hemoperfusion
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hemoperfusion Cartridge Market Size Forecast by Applications
11.10.1 Overdose
11.10.2 Specific Intoxications
11.10.3 Certain Autoimmune Diseases
11.10.4 Hepatic Encephalopathy
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hemoperfusion Cartridge Analysis and Forecast
12.1 Introduction
12.2 Latin America Hemoperfusion Cartridge Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hemoperfusion Cartridge Market Size Forecast by Type
12.6.1 Charcoal Hemoperfusion
12.6.2 Certain Resins Hemoperfusion
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hemoperfusion Cartridge Market Size Forecast by Applications
12.10.1 Overdose
12.10.2 Specific Intoxications
12.10.3 Certain Autoimmune Diseases
12.10.4 Hepatic Encephalopathy
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hemoperfusion Cartridge Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hemoperfusion Cartridge Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hemoperfusion Cartridge Market Size Forecast by Type
13.6.1 Charcoal Hemoperfusion
13.6.2 Certain Resins Hemoperfusion
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hemoperfusion Cartridge Market Size Forecast by Applications
13.10.1 Overdose
13.10.2 Specific Intoxications
13.10.3 Certain Autoimmune Diseases
13.10.4 Hepatic Encephalopathy
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hemoperfusion Cartridge Market: Competitive Dashboard
14.2 Global Hemoperfusion Cartridge Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baihe Medical
14.3.2 Baxter International
14.3.3 Asahi Kasei Corporation
14.3.4 Jafron Biomedical
14.3.5 Kaneka Pharma
14.3.6 Kangbei Medical Device
14.3.7 Toray Medical
14.3.8 Biosun Corporation
14.3.9 CytoSorbents
